Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 7/2018

01-07-2018 | Supplementary Presentation

Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation

Authors: S. S. L. Goh, P. S. M. Lai, A. T. B. Tan, S. Ponnampalavanar

Published in: Osteoporosis International | Issue 7/2018

Login to get access

Abstract

A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in human immunodeficiency virus (HIV)-infected individuals. The prevalence of osteopenia/osteoporosis in HIV-infected and antiretroviral therapy (ART)-treated individuals was significantly higher than respective controls. Evidence regarding bone loss within first year of HIV infection or ART initiation was preliminary.
Appendix
Available only for authorised users
Literature
1.
Goh SSL et al (2017) Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors. Osteoporos Int
Metadata
Title
Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation
Authors
S. S. L. Goh
P. S. M. Lai
A. T. B. Tan
S. Ponnampalavanar
Publication date
01-07-2018
Publisher
Springer London
Published in
Osteoporosis International / Issue 7/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4379-y

Other articles of this Issue 7/2018

Osteoporosis International 7/2018 Go to the issue

Letter

Gout as a risk factor for osteoporosis: response to comments by Kostev

Short Communication

Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study

Letter

Association between gout and osteoporosis risk in the United Kingdom

Original Article

The relation of low levels of bone mineral density with coronary artery calcium and mortality

Original Article

Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis

Original Article

Relationships between markers of inflammation and bone density: findings from the Hertfordshire Cohort Study